Direct Plan · Growth · Index Funds · Scheme code 149389
NAV₹18.8481as on 30 Oct 2026
Fund houseICICI Prudential Mutual Fund
CategoryIndex Funds
Plan & optionDirect · Growth
History4.7 years
Returns (%)
1M
3M
6M
1Y
3Y
5Y
7Y
10Y
Launch
This scheme
1.73
4.37
7.80
13.02
17.62
—
—
—
17.05
Nifty 100 benchmark
0.25
3.49
-1.52
1.84
10.52
9.38
—
—
12.79
Index Funds category median
—
—
—
0.39
7.46
6.40
—
10.97
—
Over a year annualised (CAGR), under a year absolute. Computed from AMFI's published
NAV history for this scheme.
Risk
Volatility
Sharpe
Sortino
Beta
Alpha
Max fall
R²
This scheme
17.9%
0.62
0.95
1.14
5.96%
-21.1%
83.32
Nifty 100 benchmark
14.4%
0.28
0.40
—
—
-37.0%
—
Risk-free rate 6.5%. Beta, alpha and R² are regressed on the
36 months this scheme and its benchmark share.
Growth of ₹100 since launch
Drawdown from peak (%)
Every one-year period it has lived through
Windows
Worst
Median
Best
Periods that lost money
907
-6.1%
13.7%
61.2%
7%
Every one-year holding period in this scheme's history, not just the last one — the
spread a real investor would have met depending only on when they started.
How it behaves against its benchmark
Up capture
Down capture
Correlation
Tracking error
Information ratio
Treynor
129%
105%
0.91
7.6%
0.86
9.34
Up capture is how much of the benchmark's gain this scheme kept in the months the
benchmark rose; down capture, how much of its fall it took. Below 100 on the down side and above it
on the up side is the combination every fund is trying for and few reach.
Measured over the 36 months this scheme and
Nifty 100 share.
ICICI Prudential Nifty Midcap 150 Index Fund
Direct Plan · Growth
Allocation
By asset
Equity
98.07%
REITs / InvITs
1.86%
Cash & Equivalents
0.07%
By market cap
Large Cap
5.64%
Mid Cap
91.75%
Small Cap
2.54%
Concentration
Number of stocks
150
Top 5 stocks
9.44%
Top 10 stocks
17.04%
Top 20 stocks
29.87%
Lines in the filing
152
Largest holding
2.05%
Largest sector
Pharmaceuticals & Biotechnology 9.03%
Effective stocks
109.1
Sectors held
41
Cash
0.07%
Effective stocks is what the concentration works out to: a fund holding
150 names but most of its money in a few
behaves like a fund of 109. Cash includes repo and TREPS, which
every fund parks money in overnight.
Sector split
Pharmaceuticals & Biotechnology
9.03%
Banks
8.57%
Finance
6.76%
Electrical Equipment
5.88%
Retailing
5.55%
Capital Markets
4.66%
Auto Components
4.56%
It - Software
4.37%
Consumer Durables
4.30%
Insurance
3.80%
Realty
3.36%
Industrial Products
2.96%
Leisure Services
2.78%
Financial Technology (Fintech)
2.67%
Power
2.43%
Healthcare Services
2.03%
Beverages
2.01%
Telecom - Services
1.91%
Units of Real Estate Investment Trust (REITs)
1.86%
Fertilizers & Agrochemicals
1.83%
ICICI Prudential Nifty Midcap 150 Index Fund
Direct Plan · Growth · holdings
Top 30 holdings
#
Company
Sector
Shares held
Value ₹ cr
% of fund
1
Multi Commodity Exchange Of India Ltd.
Capital Markets
77,898
26
2.05%
2
The Federal Bank Ltd.
Banks
754,248
24
1.90%
3
Laurus Labs Ltd.
Pharmaceuticals & Biotechnology
118,941
24
1.87%
4
EMBASSY OFFICE PARKS REIT
Units of Real Estate Investment Trust (REITs)
538,255
23
1.86%
5
One 97 Communications Ltd
Financial Technology (Fintech)
131,485
22
1.76%
6
Hero Motocorp Ltd.
Automobiles
39,646
21
1.65%
7
The Indian Hotels Company Ltd.
Leisure Services
268,163
20
1.55%
8
COFORGE Ltd.
It - Software
106,351
19
1.48%
9
Bharat Heavy Electricals Ltd.
Electrical Equipment
444,952
18
1.47%
10
IndusInd Bank Ltd.
Banks
201,137
18
1.44%
11
AU Small Finance Bank Ltd.
Banks
177,562
18
1.43%
12
Persistent Systems Ltd.
It - Software
33,220
18
1.40%
13
Dixon Technologies (India) Ltd.
Consumer Durables
12,719
17
1.33%
14
IDFC First Bank Ltd.
Banks
2,027,939
17
1.31%
15
Bharat Forge Ltd.
Auto Components
84,860
16
1.30%
16
Ge Vernova T&D India Ltd.
Electrical Equipment
37,839
16
1.26%
17
Lenskart Solutions Ltd.
Retailing
223,930
15
1.22%
18
Life Insurance Corporation of India
Insurance
387,381
15
1.22%
19
Lupin Ltd.
Pharmaceuticals & Biotechnology
74,182
15
1.20%
20
Suzlon Energy Ltd.
Electrical Equipment
3,715,274
15
1.17%
21
Indus Towers Ltd.
Telecom - Services
393,114
15
1.17%
22
Info Edge (India) Ltd.
Retailing
118,342
14
1.15%
23
Aurobindo Pharma Ltd.
Pharmaceuticals & Biotechnology
84,400
14
1.12%
24
Ashok Leyland Ltd.
Agricultural, Commercial & Construction Vehicles
874,069
13
1.07%
25
FSN E-Commerce Ventures Ltd.
Retailing
418,021
13
1.06%
26
Marico Ltd.
Agricultural Food & Other Products
161,859
13
1.01%
27
Fortis Healthcare Ltd.
Healthcare Services
159,126
12
0.97%
28
United Spirits Ltd.
Beverages
90,219
12
0.97%
29
APL Apollo Tubes Ltd.
Industrial Products
55,587
12
0.97%
30
ICICI Lombard General Insurance Company Ltd.
Insurance
74,367
12
0.94%
ICICI Prudential Nifty Midcap 150 Index Fund
Direct Plan · Growth · where the money sits
What the manager did last month
Between the filings of 31 Mar 2026 and 31 Jul 2026.
A position grows because the manager bought or because the price rose; only the share count separates them.
Bought
Sold
New positions
Sold out of
Price move of holdings
₹240 cr
₹0 cr
0
0
+21.73%
Stock
Shares traded
Shares
Price
Value ₹ cr
Added to
BSE Ltd.
22,084
+21.7%
+35.9%
8.1
The Federal Bank Ltd.
133,991
+21.9%
+38.3%
4.8
Laurus Labs Ltd.
21,026
+21.7%
+83.0%
3.8
Hero Motocorp Ltd.
7,017
+21.7%
+6.4%
3.8
COFORGE Ltd.
21,834
+26.2%
+54.4%
3.8
Multi Commodity Exchange Of India Ltd.
13,783
+21.7%
+12.7%
3.7
IndusInd Bank Ltd.
35,613
+21.8%
+34.6%
3.6
Vishal Mega Mart Ltd.
314,003
+59.3%
+1.7%
3.4
Not equity
Previous filing
This filing
Change
Cash, repo and TREPS
₹0 cr
₹0 cr
+₹0 cr
The list above is stocks and fund units. Treasury bills, repo and money-market
lines roll over every month by design — they are not decisions, so they are totalled here rather
than listed as activity.
Not investment advice. InvestVerdict is not a SEBI-registered Investment
Adviser or Research Analyst. Every figure is computed from AMFI's published NAV history and the
portfolio the AMC filed with AMFI; none of it is a recommendation to buy, hold or sell. Past
returns do not predict future ones. Generated 31 Oct 2026.
